After correctly calling last week's dip and selling both Tesla #TSLA and NVIDIA #NVDA, Jim explains why he still believes the market has more room to fall, even with positive headlines about Elon Musk’s pay package.
4 extracted signals · 4 resolved · 0 still active
StockInvest.us09 Nov 2025, 18:38 UTC
AI-generated source summary
The analysis provides insights on stock picks for week 46. Guardant Health is currently at $96.72, but it's recommended to wait for it to drop to around $75, with support not present until $73, anticipating future earnings. Applied Digital, trading with a bullish trend, requires an additional look as it has an upturn. Astronics also displays an inclination for a bullish trend. Nio will be held, while an overbought Nvidia and Tesla were sold, a smart move. It is expected red week but the end can change. Overall view to prefer to be on US market.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
4 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from StockInvest.us
ONDS Ondas Inc. Stock Analysis: 5 Scenarios Before Q2 Call Aug 13, 2026 - Buy Signal or Crash? 🚀
SNDK Stock Jumped 26% — Buy Before Earnings or Wait for a Pullback?
META Stock Analysis: After 10% After-Hours Drop - Thursday Predicted Opening Price + 3 Scenarios 📉
VRT Vertiv: After Jul 29 Q2 Call & Crash - 5 Stock Signals + Thursday Predicted Opening Price? 📉
SNDK Sandisk: 3 Price Scenarios After 2,000% Rally & 7% Crash - Can 200% Returns Happen? 📈
Red Days for SNDK? Tuesday Premarket Hit + 2 Price Scenarios
StockInvest.us
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.